IRON TRIANGLE PARTNERS LP
Q3 2023 Form 13-F
COS COB, CONNECTICUT
CIK 0001779763
· CRD 302077
· SEC-registered investment adviser
$684.2M Reported Value Total
IRON TRIANGLE PARTNERS LP reports 7 total accounts under management (AUM). There are 7 discretionary accounts valued at $1,128,405,652, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $359.6M gross asset value
Hedge Fund: $359.6M
Source: Form ADV filed 2026-03-24
Reported value
$684.2M
Quarter over quarter
-11.2%
Holdings
23
Top-10 concentration
63.2%
Key People
Form ADV owners & control persons
Kevin Thomas Molloy
LIMITED PARTNER
Michael John O'Brien
CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2023 13F record
Q3 2023 13F filing summary
| Period of report | September 30, 2023 |
|---|---|
| Filed | November 14, 2023 |
| Form | 13F-HR |
| Reported value | $684.2M |
| Positions | 23 |
| Change in reported value | -8.5% |
| New positions | 6 |
| Exited positions | 5 |
| Position turnover | 39.3% |
| Top-10 concentration | 63.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2025 13F
Filed Feb 17, 2026
|
27 | $874.7M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
25 | $703.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
26 | $651.2M |
|
Q1 2025 13F
Filed May 15, 2025
|
27 | $634.4M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
22 | $908.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
24 | $721.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
24 | $983.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
28 | $976.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $772.9M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
23 | $684.2M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
22 | $748.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
27 | $693.2M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
26 | $557.8M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
27 | $572.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
24 | $771.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
28 | $840.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
25 | $717.7M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
26 | $696.8M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
26 | $970.8M |
|
Q1 2021 13F
Filed May 17, 2021
|
27 | $786.5M |
5 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | UHS UNIVERSAL HLTH SVCS INC | $63.1M | 9.22% |
| 2 | ACHC ACADIA HEALTHCARE COMPANY IN | $53.8M | 7.86% |
| 3 | DXCM DEXCOM INC | $52.8M | 7.71% |
| 4 | UTHR UNITED THERAPEUTICS CORP DEL | $47.6M | 6.95% |
| 5 | ISRG INTUITIVE SURGICAL INC | $41.5M | 6.07% |
| 6 | ELAN ELANCO ANIMAL HEALTH INC | $38.4M | 5.61% |
| 7 | ABBV ABBVIE INC | $37.3M | 5.45% |
| 8 | APLS APELLIS PHARMACEUTICALS INC | $33.5M | 4.89% |
| 9 | GKOS GLAUKOS CORP | $32.4M | 4.73% |
| 10 | ICLR ICON PLC | $32.0M | 4.68% |
| 11 | MCK MCKESSON CORP | $30.4M | 4.45% |
| 12 | LEGN LEGEND BIOTECH CORP | $30.4M | 4.44% |
| 13 | ESTA ESTABLISHMENT LABS HLDGS INC | $28.0M | 4.09% |
| 14 | TXG 10X GENOMICS INC | $27.5M | 4.02% |
| 15 | BRKR BRUKER CORP | $26.8M | 3.92% |
| 16 | BSX BOSTON SCIENTIFIC CORP | $21.1M | 3.09% |
| 17 | BKD BROOKDALE SR LIVING INC | $17.5M | 2.56% |
| 18 | ITCI INTRA-CELLULAR THERAPIES INC | $17.2M | 2.52% |
| 19 | EXAS EXACT SCIENCES CORP | $17.1M | 2.49% |
| 20 | PACB PACIFIC BIOSCIENCES CALIF IN | $15.0M | 2.2% |
Values as reported on the Q3 2023 Form 13F. Every position is in the holdings table below.